Search entire site
Searchresult 1 - 2 of 2. You filter by “Decisions” and “Abuse of dominant position”.
File | Decisions | 02-12-2014
More information about this publication
Publication | Decisions
Decision on possible abuse of a dominant position by AstraZeneca about pricing strategy for Nexium. Dominance has not been established. No sanction has been imposed.